GuidelineBulletin du cancer2020
[COVID-19 and people followed for breast cancer: French guidelines for clinical practice of Nice-St Paul de Vence, in collaboration with the Collège Nationale des Gynécologues et Obstétriciens Français (CNGOF), the Société d'Imagerie de la Femme (SIFEM), the Société Française de Chirurgie Oncologique (SFCO), the Société Française de Sénologie et Pathologie Mammaire (SFSPM) and the French Breast Cancer Intergroup-UNICANCER (UCBG)].
Open access · bronzeAbstract readPractice Guideline
In one paragraph
Guideline in Bulletin du cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
3.2field-weighted citation impact, top 6% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.
- Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence.Critical reviews in oncology/hematology · 2020Pooled it
- [Breast cancer screening and diagnosis at the end of the COVID-19 confinement period, practical aspects and prioritization rules: recommendations of 6 French health professionals societies].Bulletin du cancer · 2020Guideline
- Analysis of the impact of the COVID-19 pandemic on the stage at diagnosis in breast cancer patients at a French comprehensive cancer centre, through two different methods: a preliminary study.Breast cancer research and treatment · 2025Article
- Did the COVID-19 pandemic delay treatment for localized breast cancer patients? A multicenter study.PloS one · 2024Article
- Impact of the COVID-19 pandemic on clinical presentation, treatments, and outcomes of new breast cancer patients: A retrospective multicenter cohort study.Cancer medicine · 2023Article
- Article
- Challenges faced in the cancer diagnosis and management-COVID-19 pandemic and beyond-Lessons for future.Heliyon · 2022Review
- Is cancer a prognostic factor for severe COVID-19, especially for breast cancer patients?Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique · 2022Review
- Organisation of cancer care in troubling times: A scoping review of expert guidelines and their implementation during the COVID-19 pandemic.Critical reviews in oncology/hematology · 2022Article
- The psychological impact of therapeutic changes during the COVID-19-lockdown for gynaecological and breast cancer patientsJournal of gynecology obstetrics and human reproduction · 2022Article
- Impact of the COVID-19 lockdown in France on the diagnosis and staging of breast cancers in a tertiary cancer centre.European radiology · 2022Article
- Cardiac involvement in cancer patients under chemotherapy and diagnosed with COVID-19: case report and literature review.The Pan African medical journal · 2022Review
- A New Modality for Breast Cancer Diagnosis During the COVID-19 Pandemic: A Case Report.European journal of breast health · 2022Article
- Impact of the First Wave of the COVID-19 Pandemic on the Lyon University Hospital Cancer Institute (IC-HCL).Cancers · 2021Article
- Multicenter evaluation of breast cancer patients' satisfaction and experience with oncology telemedicine visits during the COVID-19 pandemic.British journal of cancer · 2021Observational
- [Covid-19 and breast cancer: First lessons of a pandemic].Gynecologie, obstetrique, fertilite & senologie · 2021Article
- Impact of COVID-19 on healthcare organisation and cancer outcomes.European journal of cancer (Oxford, England : 1990) · 2021Article
- Severe Impact of Covid-19 Pandemic on Breast Cancer Care in Italy: A Senonetwork National Survey.Clinical breast cancer · 2021Article
- Radiology management of a 'breast unit' during COVID-19 pandemic: a single institution experience.Future oncology (London, England) · 2020Article
- A multi-institutional assessment of COVID-19-related risk in radiation oncology.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
41 authors at 20 institutions in 4 countries.
Joseph GligorovInstitut Universitaire de Cancérologie, AP-HP, Sorbonne Université, Paris, France. Electronic address: joseph.gligorov@aphp.fr.
Thomas BachelotCentre Léon-Bérard, Lyon, France.
Jean-Yves PiergaInstitut Curie, Université Paris Centre, Paris, France.
Eric-Charles AntoineInstitut du sein Henri-Hartmann, Neuilly, France.
Corinne BalleyguierInstitut Gustave-Roussy, Villejuif, France.
Emmanuel BarrangerCentre Antoine-Lacassagne, Nice, France.
Yazid BelkacemiUniversité Paris Est Créteil, Hôpitaux Universitaires Henri-Mondor AP-HP, Créteil, France.
Hervé BonnefoiInstitut Bergonié, Bordeaux, France.
François-Clément BidardInstitut Curie, Université Paris Centre, Paris, France.
Luc CeugnartCentre Oscar-Lambret, Lille, France.
Jean-Marc ClasseInstitut de Cancérologie de l'Ouest, Nantes, France.
Paul CottuInstitut Curie, Université Paris Centre, Paris, France.
Charles CoutantCentre Georges-François-Leclerc, Dijon, France.
Bruno CutuliInstitut du Cancer Courlancy Reims, Reims, France.
Florence DalencInstitut Claudius-Regaud, Toulouse, France.
Emile DaraiInstitut Universitaire de Cancérologie, AP-HP, Sorbonne Université, Paris, France.
Veronique DierasCentre Eugène-Marquis, Rennes, France.
Nadine DohollouPolyclinique Bordeaux Nord Aquitaine, Bordeaux, France.
Sylvie GiacchettiHôpital Universitaire St.-Louis AP-HP, Paris, France.
Anthony GoncalvesInstitut Paoli-Calmette, Marseille, France.
Anne-Claire Hardy-BessardCentre Armoricain d'Oncologie CARIO, Plerin, France.
Gilles HouvenaeghelInstitut Paoli-Calmette, Marseille, France.
Jean-Philippe JacquinInstitut de Cancérologie de la Loire, St.-Priest-en-Jarez, France.
William JacotInstitut du Cancer, Montpellier, France.
Christelle LevyCentre François-Baclesse, Caen, France.
Carole MathelinCentre Hospitalo-Universitaire de Strasbourg, Strasbourg, France.
Israel NisandCentre Hospitalo-Universitaire de Strasbourg, Strasbourg, France.
Thierry PetitCentre Paul-Strauss, Strasbourg, France.
Thierry PetitCentre Paul-Strauss, Strasbourg, France.
Edouard PonceletCentre Hospitalier de Valenciennes, Valenciennes, France.
Sofia RiveraInstitut Gustave-Roussy, Villejuif, France.
Roman RouzierInstitut Curie, Université Paris Centre, Paris, France.
Rémy SalmonClinique Saint-Jean-de-Dieu, Paris, France.
Florian ScottéInstitut Gustave-Roussy, Villejuif, France.
Jean-Philippe SpanoInstitut Universitaire de Cancérologie, AP-HP, Sorbonne Université, Paris, France.
Catherine UzanInstitut Universitaire de Cancérologie, AP-HP, Sorbonne Université, Paris, France.
Laurent ZelekHôpital Universitaire Avicenne, Bobigny, France.
Marc SpielmannInstitut Français du Sein, Paris, France.
Frédérique Penault-LlorcaCentre Jean-Perrin, Clermont-Ferrand, France.
Moise NamerRPC Nice-St.-Paul-de-Vence, Nice, France.
Suzette DelalogeInstitut Gustave-Roussy, Villejuif, France.
Sorbonne Université · FRInstitut Curie · FRInstitut Gustave Roussy · FREurométropole de Strasbourg · FRHôpitaux Universitaires de Strasbourg · FRInstitut de Cancérologie de l'Ouest · FRInstitut Paoli-Calmettes · FRCentre Antoine Lacassagne · FRCentre Eugène Marquis · FRCentre François Baclesse · LUCentre Georges François Leclerc · FRCentre Hospitalier de Valenciennes · FRCentre Hospitalier Universitaire Henri-Mondor · FRCentre Léon Bérard · FRCentre Oscar Lambret · FRClinique Hartmann · FRClinique Saint Jean · BEHôpital Avicenne · FRHôpital Saint-Louis · FRInstitut Bergonié · FR
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
BetacoronavirusBreast NeoplasmsCarcinoma, Intraductal, NoninfiltratingCoronavirus InfectionsPandemicsPneumonia, ViralChinaCOVID-19FemaleFranceHumansInfluenza, HumanItalyNeoplasmsSARS-CoV-2Societies, MedicalBreast cancerCancer du seinCovid-19GuidelinesRecommandationSARS-CoV-2
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.